Search Results
Jun 01, 2026, 09:00 ET Devraj Sen to become President of Trihedral on July 1, 2026
even while navigating the retirement of long-tenured colleagues. Through those transitions, Trihedral has maintained the kind of low attrition that is rare in the software industry, and a direct reflection of the culture Devraj has helped build and protect. "Devraj has earned the trust and respect
More news about: Delta Electronics (Americas)
Jun 01, 2026, 09:00 ET The Luxury Collection Announces the Unveiling of The London, a Luxury Collection Hotel, New York City
setting," said Geoffery Mills, General Manager, The London, a Luxury Collection Hotel, New York City. "In a city where space is increasingly rare, the hotel presents a more residential way to stay, from expansive suites with separate living areas to sweeping views of Central Park and the Manhattan
More news about: Marriott International, Inc.
Jun 01, 2026, 09:00 ET PEOPLE INCORPORATED PROPOSES TO ACQUIRE MGM RESORTS INTERNATIONAL FOR $48.30 PER SHARE IN CASH
today owns 26.1% of the outstanding common stock of MGM. "We began investing in MGM nearly six years ago because we believed it represented a rare kind of business: one with real world assets that AI cannot easily replicate or disintermediate and exceptional digital growth opportunities. That conviction
More news about: People Incorporated
Jun 01, 2026, 08:43 ET Holladay Distillery Marks Historic Milestones Ahead of 170th Anniversary Year
Mississippi still operating at its original location. On December 5, 2026, the distillery will officially celebrate 170 years of continuous operation, a rare milestone few American distilleries can claim.While the distillery reflects on nearly two centuries of history, the Holladay Bourbon portfolio
More news about: Holladay Distillery | McCormick Distilling Co.
Jun 01, 2026, 08:35 ET CAMICO Partners with Pibit.AI to Streamline Underwriting
traceable data, the company helps its clients optimize bind ratios, reduce loss ratios, and process higher volumes."CAMICO has built something rare: an insurer with deep domain expertise and a long-term commitment to its policyholders" said Akash (AK) Agarwal, founder-CEO at Pibit.AI. "For decades,
More news about: Pibit.AI
Jun 01, 2026, 08:34 ET Morphy's May 21-23 Vegas Coin-Op & Advertising Auction Hit The Jackpot, Topping $3 Million
Highlights: Circa 1905-1910 Caille Brothers Mfg. (Detroit) 'Centaur' triple slot machine with rare harp castings, $227,500; circa 1900-1905 Mills Novelty Co. (Chicago) '20th Century' slot machine, $92,250DENVER, Pa., June
More news about: Morphy Auctions
Jun 01, 2026, 08:31 ET The Evolving EGFR NSCLC Market: 8 Emerging Late-stage Therapies to Watch | DelveInsight
is emerging as a promising targeted therapy with the potential to enhance the treatment landscape for EGFR-mutant NSCLC, especially in patients with rare EGFR alterations and CNS involvement, according to Aparna Thakur, Assistant Project Manager, Forecasting at DelveInsight. Should ongoing global studies
More news about: DelveInsight Business Research, LLP
Jun 01, 2026, 08:30 ET Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business
President of Servier. "This acquisition aims to provide targeted therapies to patients with rare neuromuscular disorders. Developing treatments for young and adult patients, with highly debilitating rare conditions and limited to no options today, is at the heart of our mission.""We believe
More news about: Servier
Jun 01, 2026, 08:30 ET Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business
President of Servier. "This acquisition aims to provide targeted therapies to patients with rare neuromuscular disorders. Developing treatments for young and adult patients, with highly debilitating rare conditions and limited to no options today, is at the heart of our mission.""We believe
More news about: Servier
Jun 01, 2026, 08:30 ET Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
commercial capabilities required to fully realize sevasemten's potential for patients."Servier's focus on precision therapeutics and its dedication to rare neurological and neuromuscular diseases make them the ideal steward for the program," said Kevin Koch, Ph.D., President and Chief Executive Officer
More news about: Edgewise Therapeutics
Jun 01, 2026, 08:30 ET M&A Veteran Launches Schryver & Co., an Advisory Firm Built Exclusively for the Trades
Will Schryver founded the firm for this reason — to give owners an advocate who knows that landscape from the inside.Schryver & Co. brings a rare combination of perspectives to residential and commercial services M&A. Coming from the world of investment banking and private equity, the firm
More news about: Schryver & Co.
Jun 01, 2026, 08:30 ET Xtalks Announces its Life Science Webinar Calendar for June 2026
Operating Models: A Practical Guide to Harmonizing Priorities in Clinical DevelopmentJun 18 - Strengthen Participant-Site Readiness for Complex Rare Disease TrialsJun 18 - Empowering Clinical Sites to Drive Engagement and Retention among Human-Centered TrialsJun 22 - Why Level Setting
More news about: Xtalks
Jun 01, 2026, 08:20 ET 3billion Launches 3B-NEO, a Genomic Newborn Screening Service Covering 595 Clinically Actionable Genetic Conditions
step in expanding 3billion's precision medicine platform beyond rare disease diagnosis and into proactive genomic healthcare across the life cycle.Founded in 2016, 3billion provides AI-powered genomic interpretation and rare disease diagnostic services to healthcare professionals in more than
More news about: 3billion
Jun 01, 2026, 08:15 ET A Texas Start-Up's Stubborn Bet That AI Can Solve Industrial Commerce
integrated transaction layer to reduce procurement friction for the energy, manufacturing, and petrochemical sectors. Resin8 is led by a team with a rare combination of industry expertise and technical know-how and serves customers in the U.S. and Canadian industrial markets. For more information, visit
More news about: Resin8
Jun 01, 2026, 08:00 ET Rare Redo Bentall Surgery Successfully Performed on 72-Year-Old Patient from Mizoram at Manipal Hospital
KOLKATA, India, June 1, 2026 /PRNewswire/ -- A 72-year-old man from Mizoram, has successfully undergone rare Redo Bentall surgery at Manipal Hospital Broadway under the expertise of Dr Siddhartha Mukhopadhyay, Consultant, Thoracic & Vascular Surgery.
More news about: Manipal Hospitals
Jun 01, 2026, 08:00 ET Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics
significantly accelerate our analyses, potentially by an order of magnitude, and enables us to probe critical low‑abundance species in far greater detail. These rare molecular populations are essential for delineating the mechanisms that drive human disease."The Cyclic IMS P20 Mass Spectrometer also brings
More news about: Waters Corporation
Jun 01, 2026, 08:00 ET Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics
significantly accelerate our analyses, potentially by an order of magnitude, and enables us to probe critical low‑abundance species in far greater detail. These rare molecular populations are essential for delineating the mechanisms that drive human disease."The Cyclic IMS P20 Mass Spectrometer also brings
More news about: Waters Corporation
Jun 01, 2026, 08:00 ET Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development
the development of targeted radiotherapies, today announced the appointment of Steffen Heeger, MD, MSc, as Chief Medical Officer. Dr. Heeger brings a rare combination of radiotherapy expertise, global oncology drug development leadership, and public-company experience. Over his career, he has translated
More news about: Actinium Pharmaceuticals, Inc.
Jun 01, 2026, 07:30 ET Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation
("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies for rare and common diseases, today announced the initiation of first-in-human (FIH) dosing for BHV-8100, its oral, brain-penetrant pyruvate kinase M2 isoform
More news about: Biohaven Ltd.
Jun 01, 2026, 07:00 ET Cheung Kong Graduate School of Business Opens First Permanent Beijing Campus
Located in the heart of Beijing's Ciqikou, or "China's Gateway," the new campus sits at a rare geographical and symbolic intersection in Beijing. On one side stand the Forbidden City and the Temple of Heaven, symbols of China's rich history and
More news about: Cheung Kong Graduate School of Business (CKGSB)
Jun 01, 2026, 07:00 ET Zennify names Michael Rouleau CEO to lead the firm's next chapter as the definitive Data, AI, and CX partner for regulated industries
sales, delivery, and the operational build-out that has carried Zennify through its AI transformation."What we've built together at Zennify is rare. An outcome-focused AI-first organization that customers trust, with real depth across data engineering, AI, and customer experience," said Rouleau.
More news about: Zennify
Jun 01, 2026, 06:46 ET Cheung Kong Graduate School of Business Opens First Permanent Beijing Campus
Located in the heart of Beijing's Ciqikou, or "China's Gateway," the new campus sits at a rare geographical and symbolic intersection in Beijing. On one side stand the Forbidden City and the Temple of Heaven, symbols of China's rich history and
More news about: Cheung Kong Graduate School of Business (CKGSB)
Jun 01, 2026, 06:30 ET Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
animal studies toward human trials, the possibilities offered by Skyhawk's small molecule platform are very exciting."Huntington's disease is a rare, hereditary, and ultimately fatal neurodegenerative disorder affecting more than 40,000 symptomatic individuals in the United States, with hundreds of
More news about: Skyhawk Therapeutics
Jun 01, 2026, 06:30 ET Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
animal studies toward human trials, the possibilities offered by Skyhawk's small molecule platform are very exciting."Huntington's disease is a rare, hereditary, and ultimately fatal neurodegenerative disorder affecting more than 40,000 symptomatic individuals in the United States, with hundreds of
More news about: Skyhawk Therapeutics
Jun 01, 2026, 06:00 ET From the founders of iS Clinical: Icon Skincare Launches with a Joyful, Curated Approach to Prestige Skincare, Reimagining the Rituals of Hollywood's Golden Age
signature blends of sustainably sourced botanicals, antioxidants, and innovative acid combinations, with many products featuring royal jelly, a unique, rare, and costly "super-power" ingredient backed by substantial clinical research. Simply put, Icon Skincare products are designed to nourish, support skin
More news about: Icon Skincare